Matthew T. Hueman

2.2k total citations
56 papers, 1.7k citations indexed

About

Matthew T. Hueman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Matthew T. Hueman has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Matthew T. Hueman's work include Immunotherapy and Immune Responses (22 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Matthew T. Hueman is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Matthew T. Hueman collaborates with scholars based in United States, Switzerland and Germany. Matthew T. Hueman's co-authors include George E. Peoples, Sathibalan Ponniah, Catherine E. Storrer, Doris A. Taylor, B. Zane Atkins, Kelley A. Hutcheson, Jarrod P. Holmes, Timothy M. Pawlik, Charles M. Vollmer and Craig D. Shriver and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Matthew T. Hueman

56 papers receiving 1.7k citations

Peers

Countries citing papers authored by Matthew T. Hueman

Since Specialization

Citations

This map shows the geographic impact of Matthew T. Hueman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew T. Hueman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew T. Hueman more than expected).

Fields of papers citing papers by Matthew T. Hueman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew T. Hueman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew T. Hueman. The network helps show where Matthew T. Hueman may publish in the future.

Co-authorship network of co-authors of Matthew T. Hueman

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew T. Hueman. A scholar is included among the top collaborators of Matthew T. Hueman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew T. Hueman. Matthew T. Hueman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Cell-free DNA in Serum as a Marker for the Early Detection of Tumor Recurrence in Breast Cancer Patients 2022 ·Cancer Diagnosis & Prognosis ·Alakesh Bera, Eric Russ, (unknown), (unknown), (unknown), Madhan Subramanian, Matthew T. Hueman, Harvey B. Pollard, Hai Hu, Craig D. Shriver, Meera Srivastava	5
2	Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning 2021 ·PLoS ONE ·(unknown), Huan Wang, Zhenqiu Liu, Matthew T. Hueman, (unknown), Donald E. Henson, Sheng Li, Dechang Chen	7
3	Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital 2019 ·Annals of Surgical Oncology ·(unknown), Yvonne L. Eaglehouse, Matthew T. Hueman, (unknown), Craig D. Shriver, Rachel E. Ellsworth	9
4	Expanding the TNM for cancers of the colon and rectum using machine learning: a demonstration 2019 ·ESMO Open ·Matthew T. Hueman, Huan Wang, Donald E. Henson, Dechang Chen	14
5	The anatomy of the TNM for colon cancer 2017 ·Journal of Gastrointestinal Oncology ·Donald E. Henson, Matthew T. Hueman, Dechang Chen, (unknown), Huan Wang, Arnold M. Schwartz	5
6	An Algorithm for Creating Prognostic Systems for Cancer 2016 ·Journal of Medical Systems ·Dechang Chen, Huan Wang, Sheng Li, Matthew T. Hueman, Donald E. Henson, Arnold M. Schwartz, (unknown)	13
7	Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes 2014 ·Journal of Experimental & Clinical Cancer Research ·Craig D. Shriver, Matthew T. Hueman, Rachel E. Ellsworth	9
8	Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide 2010 ·Vaccine ·Jeremy D. Gates, Guy T. Clifton, Linda C. Benavides, (unknown), Mark G. Carmichael, Matthew T. Hueman, Jarrod P. Holmes, (unknown), (unknown), (unknown), (unknown), (unknown), Alexander Stojadinovic, Sathibalan Ponniah, George E. Peoples	31
9	The Impact of HER2/neuExpression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 2009 ·Clinical Cancer Research ·Linda C. Benavides, Jeremy D. Gates, Mark G. Carmichael, (unknown), Jarrod P. Holmes, Matthew T. Hueman, Elizabeth A. Mittendorf, Dianna Craig, Alexander Stojadinovic, Sathibalan Ponniah, George E. Peoples	99
10	Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/ neu -Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial 2009 ·Journal of the American College of Surgeons ·(unknown), Guy T. Clifton, Jarrod P. Holmes, Asna Amin, Mark G. Carmichael, Jeremy D. Gates, (unknown), Matthew T. Hueman, Sathibalan Ponniah, George E. Peoples	38
11	Longterm Followup Assessment of a HER2/ neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients 2009 ·Journal of the American College of Surgeons ·Jeremy D. Gates, Mark G. Carmichael, Linda C. Benavides, Jarrod P. Holmes, Matthew T. Hueman, Michael Woll, (unknown), (unknown), David G. McLeod, Sathibalan Ponniah, George E. Peoples	16
12	Optimal dose and schedule of an HER‐2/neu (E75) peptide vaccine to prevent breast cancer recurrence 2008 ·Cancer ·Jarrod P. Holmes, Jeremy D. Gates, Linda C. Benavides, Matthew T. Hueman, Mark G. Carmichael, (unknown), Dianna Craig, Elizabeth A. Mittendorf, Alexander Stojadinovic, Sathibalan Ponniah, George E. Peoples	46
13	Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 2008 ·Cancer Immunology Immunotherapy ·Asna Amin, Linda C. Benavides, Jarrod P. Holmes, Jeremy D. Gates, Mark G. Carmichael, Matthew T. Hueman, Elizabeth A. Mittendorf, Catherine E. Storrer, (unknown), Dianna Craig, Alexander Stojadinovic, Sathibalan Ponniah, George E. Peoples	23
14	Management of Extremity Soft Tissue Sarcomas 2008 ·Surgical Clinics of North America ·Matthew T. Hueman, Katherine A. Thornton, Joseph M. Herman, Nita Ahuja	19
15	Management of Gastrointestinal Stromal Tumors 2008 ·Surgical Clinics of North America ·Matthew T. Hueman, Richard D. Schulick	31
16	Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neuPeptide (AE37) Vaccine 2008 ·Journal of Clinical Oncology ·Jarrod P. Holmes, Linda C. Benavides, Jeremy D. Gates, Mark G. Carmichael, Matthew T. Hueman, Elizabeth A. Mittendorf, James L. Murray, Asna Amin, Dianna Craig, Eric von Hofe, Sathibalan Ponniah, George E. Peoples	112
17	Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology 2007 ·Oncology Reports ·Zia A. Dehqanzada, Catherine E. Storrer, Matthew T. Hueman, (unknown), Katie Harris, (unknown), Craig D. Shriver, Sathibalan Ponniah, George E. Peoples	61
18	Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine★ 2006 ·Breast Cancer Research and Treatment ·Matthew T. Hueman, Alexander Stojadinovic, Catherine E. Storrer, (unknown), Jennifer M. Gurney, Craig D. Shriver, Sathibalan Ponniah, George E. Peoples	40
19	The effect of changing gamma count threshold on sentinel lymph node accuracy 2002 ·Current Surgery ·Matthew T. Hueman, (unknown), Paul W. White, (unknown), George E. Peoples, Craig D. Shriver, Mary E. Maniscalco-Theberge	1
20	Cellular Cardiomyoplasty Improves Diastolic Properties of Injured Heart 1999 ·Journal of Surgical Research ·B. Zane Atkins, Matthew T. Hueman, Jennifer M. Meuchel, Kelley A. Hutcheson, Donald D. Glower, Doris A. Taylor	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact